Developing Drugs for Prevention of Chemotherapy-Induced Nausea and Vomiting: Draft Guidance from the United States Food and Drug Administration

The United States ◽

Nausea And Vomiting ◽

Draft Guidance ◽

United States Food ◽

Developing Pharmacologic Treatments for Eosinophilic Esophagitis: Draft Guidance from the United States Food and Drug Administration

Gastroenterology ◽

10.1053/j.gastro.2019.04.020 ◽

2019 ◽

Vol 157 (2) ◽

pp. 275-277 ◽

Cited By ~ 1

Author(s):

Erica Lyons ◽

Kathleen Donohue ◽

Jessica J. Lee

Keyword(s):

United States ◽

Drug Administration ◽

Eosinophilic Esophagitis ◽

The United States ◽

Draft Guidance ◽

United States Food ◽

States Food ◽

Pharmacologic Treatments

Effects of hypoxia and glutathione depletion on hemoglobin- and myoglobin-mediated oxidative stress toward endothelium1The opinions and assertions contained herein are the scientific views of the authors and are not to be construed as policy of the United States Food and Drug Administration or the United States Army.1

Biochimica et Biophysica Acta (BBA) - Molecular Cell Research ◽

10.1016/s0167-4889(99)00163-9 ◽

2000 ◽

Vol 1495 (2) ◽

pp. 150-159 ◽

Cited By ~ 28

Author(s):

Felice D’Agnillo ◽

Francine Wood ◽

Carlos Porras ◽

Victor W. Macdonald ◽

Abdu I. Alayash

Keyword(s):

Oxidative Stress ◽

United States ◽

United States Army ◽

Drug Administration ◽

The United States ◽

Glutathione Depletion ◽

United States Food ◽

The Regulation of Drug Products by the United States Food and Drug Administration

The Textbook of Pharmaceutical Medicine ◽

10.1002/9780470987391.ch20 ◽

2007 ◽

pp. 565-601

Author(s):

Peter Barton Hutt

Keyword(s):

United States ◽

Drug Administration ◽

The United States ◽

Drug Products ◽

United States Food ◽

GMP/ISO Quality Audit Manual for Healthcare Manufacturers and Their Suppliers, (Volume 2 - Regulations, Standards, and Guidelines) ◽

The United States Food and Drug Administration and ICH Guidance for Industry Q7A Good Manufacturing Practice Guidance for Active Pharmaceutical Ingredients

10.3109/9780203026656-8 ◽

2004 ◽

pp. 57-97

Keyword(s):

United States ◽

Drug Administration ◽

The United States ◽

Good Manufacturing Practice ◽

Active Pharmaceutical Ingredients ◽

Pharmaceutical Ingredients ◽

United States Food ◽

Regulatory Aspects of Chemistry Manufacturing and Controls for Investigational New Drug Applications and Biologic License Applications to the United States Food and Drug Administration

Comprehensive Biotechnology ◽

10.1016/b978-0-444-64046-8.00178-6 ◽

2019 ◽

pp. 473-486

Author(s):

K. Lee

Keyword(s):

United States ◽

Drug Administration ◽

The United States ◽

Regulatory Aspects ◽

New Drug ◽

United States Food ◽

The United States Food and Drug Administration

Cobert's Manual of Drug Safety and Pharmacovigilance ◽

10.1142/9789813278851_0008 ◽

2019 ◽

pp. 59-77 ◽

Cited By ~ 1

Keyword(s):

United States ◽

Drug Administration ◽

The United States ◽

United States Food ◽

Regulatory science: a special update from the United States Food and Drug Administration

Toxicology Letters ◽

10.1016/s0378-4274(99)00152-6 ◽

2000 ◽

Vol 111 (3) ◽

pp. 199-202 ◽

Cited By ~ 19

Author(s):

Kuei-Meng Wu ◽

Joseph G. DeGeorge ◽

Aisar Atrakchi ◽

Estella Barry ◽

Anita Bigger ◽

...

Keyword(s):

United States ◽

Drug Administration ◽

The United States ◽

Regulatory Science ◽

United States Food ◽

Prognostic Implication of the United States Food and Drug Administration-defined BCG-unresponsive Disease

European Urology ◽

10.1016/j.eururo.2018.09.028 ◽

2019 ◽

Vol 75 (1) ◽

pp. 8-10 ◽

Cited By ~ 11

Author(s):

Roger Li ◽

William B. Tabayoyong ◽

Charles C. Guo ◽

Graciela M. Nogueras González ◽

Neema Navai ◽

...

Keyword(s):

United States ◽

Drug Administration ◽

The United States ◽

Prognostic Implication ◽

United States Food ◽

Nonclinical Development of Radiopharmaceuticals: Regulatory Considerations for the United States Food and Drug Administration

From Morphological Imaging to Molecular Targeting ◽

10.1007/978-3-662-07310-0_8 ◽

2004 ◽

pp. 151-165

Author(s):

S. Wilson

Keyword(s):

United States ◽

Drug Administration ◽

The United States ◽

United States Food ◽

Qualification of a non-animal vaginal irritation method admitted as nonclinical assessment model (NAM) in the Incubator Phase of the United States Food and Drug Administration (US FDA) Medical Devices Development Tool (MDDT)

Toxicology in Vitro ◽

10.1016/j.tiv.2019.104680 ◽

2020 ◽

Vol 62 ◽

pp. 104680 ◽

Cited By ~ 1

Author(s):

G.-E. Costin ◽

E. Hill ◽

J. Brown ◽

A.J. Clippinger

Keyword(s):

United States ◽

Drug Administration ◽

Medical Devices ◽

The United States ◽

Assessment Model ◽

Development Tool ◽

United States Food ◽

States Food ◽

Us Fda